Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vinorelbine”

326 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 326 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT06540950
What this trial is testing

Efficacy and Safety of Concurrent Chemoradiotherapy With Oral Vinorelbine in Patients With Non-small Cell Lung Cancer

Who this might be right for
Vinorelbine
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 47
Large-scale testing (Phase 3)UnknownNCT03203590
What this trial is testing

Clinical Trial of Neoadjuvant Targeted Treatment to NSCLC Patients

Who this might be right for
2-year Disease-Free Survival
Sun Yat-sen University 590
Testing effectiveness (Phase 2)Study completedNCT00602797
What this trial is testing

Vinorelbine Tartrate and Paclitaxel in Treating Older Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Recurrent Non-Small Cell Lung CarcinomaStage IV Non-Small Cell Lung Cancer
University of Nebraska 20
Not applicableLooking for participantsNCT07041320
What this trial is testing

Oral Metronomic Vinorelbine and PD-1 Inhibitors in Elderly Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer (NSCLC)Elderly (People Aged 65 or More)
Anhui Chest Hospital 40
Testing effectiveness (Phase 2)Study completedNCT00134641
What this trial is testing

Study of Gemcitabine and Vinorelbine in Soft Tissue Sarcomas

Who this might be right for
Sarcoma, Soft Tissue
Dana-Farber Cancer Institute 40
Testing effectiveness (Phase 2)Study completedNCT01196559
What this trial is testing

Vinorelbine and Gemcitabine Combination In Platinum Resistant Recurrent Ovarian Cancer

Who this might be right for
Ovarian CancerPrimary Peritoneal CancerFallopian Tube Cancer
The Catholic University of Korea 44
Testing effectiveness (Phase 2)Ended earlyNCT03891173
What this trial is testing

L-DOS47 in Combination With Vinorelbine/Cisplatin in Lung Adenocarcinoma

Who this might be right for
Lung Adenocarcinoma
Helix BioPharma Corporation 9
Early research (Phase 1)Study completedNCT00908869
What this trial is testing

Combination of Continuous Low Doses of Vinorelbine, Cyclophosphamide and Interferon Alpha 2b (" Metronomic Chemotherapy ") for Antiangiogenic and Antivascular Effect. Trial With Pharmacodynamic Study in Adult Advanced Neoplasm

Who this might be right for
Advanced Neoplasm
Institut Paoli-Calmettes 30
Large-scale testing (Phase 3)Study completedNCT01007942
What this trial is testing

Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer

Who this might be right for
HER2/Neu Over-expressing Locally Advanced Breast CancerMetastatic Breast Cancer
Novartis Pharmaceuticals 569
Testing effectiveness (Phase 2)Study completedNCT01325428
What this trial is testing

Afatinib (BIBW2992) in HER2 (Human Epidermal Growth Factor Receptor 2)-Overexpressing Inflammatory Breast Cancer

Who this might be right for
Breast Neoplasms
Boehringer Ingelheim 26
Testing effectiveness (Phase 2)Study completedNCT00003963
What this trial is testing

Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With B-cell Non-Hodgkin's Lymphoma That Has Relapsed Following Peripheral Stem Cell Transplantation

Who this might be right for
Lymphoma
Jonsson Comprehensive Cancer Center 14
Large-scale testing (Phase 3)Study completedNCT00079287
What this trial is testing

Vinorelbine, Gemcitabine, and Docetaxel Compared With Paclitaxel and Carboplatin in Treating Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Japan Multinational Trial Organization
Early research (Phase 1)Ended earlyNCT01060514
What this trial is testing

Pazopanib + Vinorelbine in Non Small Cell Lung Cancer (NSCLC) and Breast Cancer

Who this might be right for
Metastatic Non Small Cell Lung CancerMetastatic Breast Cancer
Northwestern University 8
Testing effectiveness (Phase 2)UnknownNCT02223611
What this trial is testing

Clinical Observation of S1 Capsule for Stage Ⅱ-ⅢA Non-small Cell Lung Cancer After Complete Resection

Who this might be right for
Non-small Cell Lung Cancer Stage ⅡNon-small Cell Lung Cancer Stage ⅢA
Hebei Medical University Fourth Hospital 100
Large-scale testing (Phase 3)UnknownNCT00004100
What this trial is testing

Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Istituto Nazionale per lo Studio e la Cura dei Tumori
Testing effectiveness (Phase 2)Study completedNCT02610140
What this trial is testing

Phase II Anetumab Ravtansine as 2nd Line Treatment for Malignant Pleural Mesothelioma (MPM)

Who this might be right for
Mesothelioma
Bayer 248
Early research (Phase 1)Study completedNCT00702182
What this trial is testing

Study of Oral Vinorelbine and Erlotinib in Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
National Cancer Centre, Singapore 30
Testing effectiveness (Phase 2)Study completedNCT00022152
What this trial is testing

Vinorelbine in Treating Older Women With Stage IV Breast Cancer

Who this might be right for
Breast Cancer
Alliance for Clinical Trials in Oncology 25
Not applicableUnknownNCT04208854
What this trial is testing

Observational Study With Metronomic Oral Vinorelbine in Elderly Patients With Locally Advanced / Metastatic Non-small-cell Lung Cancer (NSCLC)

Who this might be right for
Locally Advanced/ Metastatic NSCLC
International Group of Endovascular Oncology 40
Testing effectiveness (Phase 2)Study completedNCT01050322
What this trial is testing

Safety Study in Subjects With Metastatic Breast Cancer Who Progressed After Taxanes Treatment.

Who this might be right for
BRMS1Performance Status Zero to Two for Beginning the StudyPatient With a Maximum of One Chemotherapy+1 more
Latin American Cooperative Oncology Group 142
Load More Results